25 XP   0   0   10

Level Biotechnology
Buy, Hold or Sell?

Let's analyse Level together

PenkeI guess you are interested in Level Biotechnology. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Level Biotechnology. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Level Biotechnology

I send you an email if I find something interesting about Level Biotechnology.

Quick analysis of Level (30 sec.)










What can you expect buying and holding a share of Level? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.21
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
NT$16.93
Expected worth in 1 year
NT$17.80
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
NT$7.67
Return On Investment
23.4%

For what price can you sell your share?

Current Price per Share
NT$32.75
Expected price per share
NT$31.75 - NT$
How sure are you?
50%

1. Valuation of Level (5 min.)




Live pricePrice per Share (EOD)

NT$32.75

Intrinsic Value Per Share

NT$13.35 - NT$34.49

Total Value Per Share

NT$30.28 - NT$51.43

2. Growth of Level (5 min.)




Is Level growing?

Current yearPrevious yearGrowGrow %
How rich?$16.9m$16.7m$218.4k1.3%

How much money is Level making?

Current yearPrevious yearGrowGrow %
Making money$1.9m$1.8m$137.1k7.1%
Net Profit Margin9.5%9.9%--

How much money comes from the company's main activities?

3. Financial Health of Level (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#600 / 1007

Most Revenue
#348 / 1007

Most Profit
#149 / 1007

Most Efficient
#114 / 1007

What can you expect buying and holding a share of Level? (5 min.)

Welcome investor! Level's management wants to use your money to grow the business. In return you get a share of Level.

What can you expect buying and holding a share of Level?

First you should know what it really means to hold a share of Level. And how you can make/lose money.

Speculation

The Price per Share of Level is NT$32.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Level.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Level, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$16.93. Based on the TTM, the Book Value Change Per Share is NT$0.22 per quarter. Based on the YOY, the Book Value Change Per Share is NT$-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$1.70 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Level.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.060.2%0.060.2%0.060.2%0.060.2%0.050.2%
Usd Book Value Change Per Share0.010.0%0.010.0%0.000.0%0.010.0%0.070.2%
Usd Dividend Per Share0.050.2%0.050.2%0.060.2%0.050.1%0.050.2%
Usd Total Gains Per Share0.060.2%0.060.2%0.060.2%0.060.2%0.120.4%
Usd Price Per Share0.94-0.94-0.85-0.90-0.91-
Price to Earnings Ratio15.71-15.71-15.35-16.11-17.08-
Price-to-Total Gains Ratio15.88-15.88-15.15-16.15-15.23-
Price to Book Ratio1.80-1.80-1.65-1.76-1.81-
Price-to-Total Gains Ratio15.88-15.88-15.15-16.15-15.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.011975
Number of shares988
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.05
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.060.06
Gains per Quarter (988 shares)58.5555.33
Gains per Year (988 shares)234.21221.32
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12082722418338211
24155345836676432
362380692550114653
4830106926733153874
5103813311609161911095
61246160139410992291316
71453186162812822671537
81661213186214653051758
91868240209616493431979
102076266233018323812200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%5.02.00.071.4%5.02.00.071.4%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Level

About Level Biotechnology

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.

Fundamental data was last updated by Penke on 2024-04-20 14:07:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Level Biotechnology.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Level earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Level to the Biotechnology industry mean.
  • A Net Profit Margin of 9.5% means that NT$0.10 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Level Biotechnology:

  • The MRQ is 9.5%. The company is making a profit. +1
  • The TTM is 9.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.5%TTM9.5%0.0%
TTM9.5%YOY9.9%-0.3%
TTM9.5%5Y9.1%+0.4%
5Y9.1%10Y9.1%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5%-207.2%+216.7%
TTM9.5%-218.5%+228.0%
YOY9.9%-282.4%+292.3%
5Y9.1%-432.2%+441.3%
10Y9.1%-593.8%+602.9%
1.1.2. Return on Assets

Shows how efficient Level is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Level to the Biotechnology industry mean.
  • 7.6% Return on Assets means that Level generated NT$0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Level Biotechnology:

  • The MRQ is 7.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.6%TTM7.6%0.0%
TTM7.6%YOY7.2%+0.5%
TTM7.6%5Y7.5%+0.2%
5Y7.5%10Y7.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6%-13.2%+20.8%
TTM7.6%-12.6%+20.2%
YOY7.2%-11.5%+18.7%
5Y7.5%-13.7%+21.2%
10Y7.5%-15.5%+23.0%
1.1.3. Return on Equity

Shows how efficient Level is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Level to the Biotechnology industry mean.
  • 11.4% Return on Equity means Level generated NT$0.11 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Level Biotechnology:

  • The MRQ is 11.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.4%TTM11.4%0.0%
TTM11.4%YOY10.8%+0.7%
TTM11.4%5Y11.0%+0.5%
5Y11.0%10Y10.8%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4%-16.7%+28.1%
TTM11.4%-15.8%+27.2%
YOY10.8%-14.4%+25.2%
5Y11.0%-19.0%+30.0%
10Y10.8%-19.9%+30.7%

1.2. Operating Efficiency of Level Biotechnology.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Level is operating .

  • Measures how much profit Level makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Level to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Level Biotechnology:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY10.9%-10.9%
TTM-5Y8.2%-8.2%
5Y8.2%10Y9.0%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.5%+286.5%
TTM--229.1%+229.1%
YOY10.9%-288.4%+299.3%
5Y8.2%-480.7%+488.9%
10Y9.0%-624.7%+633.7%
1.2.2. Operating Ratio

Measures how efficient Level is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.57 means that the operating costs are NT$1.57 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Level Biotechnology:

  • The MRQ is 1.565. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.565. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.565TTM1.5650.000
TTM1.565YOY1.549+0.016
TTM1.5655Y1.569-0.004
5Y1.56910Y1.568+0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5653.231-1.666
TTM1.5653.307-1.742
YOY1.5493.774-2.225
5Y1.5695.667-4.098
10Y1.5687.558-5.990

1.3. Liquidity of Level Biotechnology.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Level is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.69 means the company has NT$2.69 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Level Biotechnology:

  • The MRQ is 2.692. The company is able to pay all its short-term debts. +1
  • The TTM is 2.692. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.692TTM2.6920.000
TTM2.692YOY2.615+0.077
TTM2.6925Y2.694-0.002
5Y2.69410Y2.712-0.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6923.890-1.198
TTM2.6924.182-1.490
YOY2.6155.343-2.728
5Y2.6946.135-3.441
10Y2.7126.453-3.741
1.3.2. Quick Ratio

Measures if Level is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Level to the Biotechnology industry mean.
  • A Quick Ratio of 0.44 means the company can pay off NT$0.44 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Level Biotechnology:

  • The MRQ is 0.435. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.435. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.435TTM0.4350.000
TTM0.435YOY0.459-0.023
TTM0.4355Y0.527-0.092
5Y0.52710Y0.591-0.064
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4353.528-3.093
TTM0.4354.059-3.624
YOY0.4595.390-4.931
5Y0.5276.138-5.611
10Y0.5916.488-5.897

1.4. Solvency of Level Biotechnology.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Level assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Level to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33 means that Level assets are financed with 33.2% credit (debt) and the remaining percentage (100% - 33.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Level Biotechnology:

  • The MRQ is 0.332. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.332. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.332TTM0.3320.000
TTM0.332YOY0.3320.000
TTM0.3325Y0.321+0.011
5Y0.32110Y0.308+0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3320.339-0.007
TTM0.3320.337-0.005
YOY0.3320.273+0.059
5Y0.3210.368-0.047
10Y0.3080.391-0.083
1.4.2. Debt to Equity Ratio

Measures if Level is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Level to the Biotechnology industry mean.
  • A Debt to Equity ratio of 49.7% means that company has NT$0.50 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Level Biotechnology:

  • The MRQ is 0.497. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.497. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.497TTM0.4970.000
TTM0.497YOY0.498-0.001
TTM0.4975Y0.472+0.025
5Y0.47210Y0.447+0.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4970.388+0.109
TTM0.4970.403+0.094
YOY0.4980.342+0.156
5Y0.4720.432+0.040
10Y0.4470.461-0.014

2. Market Valuation of Level Biotechnology

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Level generates.

  • Above 15 is considered overpriced but always compare Level to the Biotechnology industry mean.
  • A PE ratio of 15.71 means the investor is paying NT$15.71 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Level Biotechnology:

  • The EOD is 16.896. Based on the earnings, the company is fair priced.
  • The MRQ is 15.709. Based on the earnings, the company is fair priced.
  • The TTM is 15.709. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.896MRQ15.709+1.187
MRQ15.709TTM15.7090.000
TTM15.709YOY15.348+0.361
TTM15.7095Y16.109-0.400
5Y16.10910Y17.080-0.971
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.896-2.249+19.145
MRQ15.709-2.553+18.262
TTM15.709-2.669+18.378
YOY15.348-4.107+19.455
5Y16.109-6.247+22.356
10Y17.080-6.499+23.579
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Level Biotechnology:

  • The EOD is 16.994. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.800. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 15.800. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.994MRQ15.800+1.193
MRQ15.800TTM15.8000.000
TTM15.800YOY15.383+0.418
TTM15.8005Y11.614+4.186
5Y11.61410Y16.109-4.495
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.994-2.858+19.852
MRQ15.800-3.288+19.088
TTM15.800-3.552+19.352
YOY15.383-5.560+20.943
5Y11.614-8.326+19.940
10Y16.109-8.881+24.990
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Level is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.80 means the investor is paying NT$1.80 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Level Biotechnology:

  • The EOD is 1.934. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.798. Based on the equity, the company is underpriced. +1
  • The TTM is 1.798. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.934MRQ1.798+0.136
MRQ1.798TTM1.7980.000
TTM1.798YOY1.654+0.144
TTM1.7985Y1.756+0.043
5Y1.75610Y1.805-0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9341.929+0.005
MRQ1.7982.090-0.292
TTM1.7982.091-0.293
YOY1.6542.881-1.227
5Y1.7563.545-1.789
10Y1.8053.936-2.131
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Level Biotechnology compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2180.2180%-0.075+135%0.312-30%2.419-91%
Book Value Per Share--16.93116.9310%16.713+1%16.516+3%16.292+4%
Current Ratio--2.6922.6920%2.615+3%2.6940%2.712-1%
Debt To Asset Ratio--0.3320.3320%0.3320%0.321+4%0.308+8%
Debt To Equity Ratio--0.4970.4970%0.4980%0.472+5%0.447+11%
Dividend Per Share--1.7001.7000%1.900-11%1.500+13%1.614+5%
Eps--1.9381.9380%1.802+8%1.818+7%1.771+9%
Free Cash Flow Per Share--1.9271.9270%1.797+7%2.804-31%2.385-19%
Free Cash Flow To Equity Per Share--1.9271.9270%-0.185+110%1.583+22%0.970+99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--34.495--------
Intrinsic Value_10Y_min--13.347--------
Intrinsic Value_1Y_max--2.951--------
Intrinsic Value_1Y_min--2.418--------
Intrinsic Value_3Y_max--9.252--------
Intrinsic Value_3Y_min--6.372--------
Intrinsic Value_5Y_max--16.018--------
Intrinsic Value_5Y_min--9.317--------
Market Cap1062832475.000+7%988190805.000988190805.0000%897325450.000+10%941135792.000+5%953885530.000+4%
Net Profit Margin--0.0950.0950%0.099-3%0.091+5%0.091+5%
Operating Margin----0%0.109-100%0.082-100%0.090-100%
Operating Ratio--1.5651.5650%1.549+1%1.5690%1.5680%
Pb Ratio1.934+7%1.7981.7980%1.654+9%1.756+2%1.8050%
Pe Ratio16.896+7%15.70915.7090%15.348+2%16.109-2%17.080-8%
Price Per Share32.750+7%30.45030.4500%27.650+10%29.000+5%29.393+4%
Price To Free Cash Flow Ratio16.994+7%15.80015.8000%15.383+3%11.614+36%16.109-2%
Price To Total Gains Ratio17.076+7%15.87615.8760%15.153+5%16.147-2%15.229+4%
Quick Ratio--0.4350.4350%0.459-5%0.527-17%0.591-26%
Return On Assets--0.0760.0760%0.072+6%0.075+2%0.075+2%
Return On Equity--0.1140.1140%0.108+6%0.110+4%0.108+6%
Total Gains Per Share--1.9181.9180%1.825+5%1.812+6%4.033-52%
Usd Book Value--16978684.80016978684.8000%16760190.900+1%16561800.540+3%16337121.343+4%
Usd Book Value Change Per Share--0.0070.0070%-0.002+135%0.010-30%0.075-91%
Usd Book Value Per Share--0.5230.5230%0.516+1%0.510+3%0.503+4%
Usd Dividend Per Share--0.0530.0530%0.059-11%0.046+13%0.050+5%
Usd Eps--0.0600.0600%0.056+8%0.056+7%0.055+9%
Usd Free Cash Flow--1932547.8001932547.8000%1802489.700+7%2811603.360-31%2391487.843-19%
Usd Free Cash Flow Per Share--0.0600.0600%0.056+7%0.087-31%0.074-19%
Usd Free Cash Flow To Equity Per Share--0.0600.0600%-0.006+110%0.049+22%0.030+99%
Usd Market Cap32841523.478+7%30535095.87530535095.8750%27727356.405+10%29081095.973+5%29475062.877+4%
Usd Price Per Share1.012+7%0.9410.9410%0.854+10%0.896+5%0.908+4%
Usd Profit--1943764.5001943764.5000%1806599.400+8%1823032.020+7%1775500.757+9%
Usd Revenue--20412879.90020412879.9000%18324101.700+11%20037401.640+2%19638980.571+4%
Usd Total Gains Per Share--0.0590.0590%0.056+5%0.056+6%0.125-52%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+21 -1410Y+22 -13

3.2. Fundamental Score

Let's check the fundamental score of Level Biotechnology based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.896
Price to Book Ratio (EOD)Between0-11.934
Net Profit Margin (MRQ)Greater than00.095
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.435
Current Ratio (MRQ)Greater than12.692
Debt to Asset Ratio (MRQ)Less than10.332
Debt to Equity Ratio (MRQ)Less than10.497
Return on Equity (MRQ)Greater than0.150.114
Return on Assets (MRQ)Greater than0.050.076
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Level Biotechnology based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose32.750
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets822,673
Total Liabilities273,201
Total Stockholder Equity549,472
 As reported
Total Liabilities 273,201
Total Stockholder Equity+ 549,472
Total Assets = 822,673

Assets

Total Assets822,673
Total Current Assets680,499
Long-term Assets142,174
Total Current Assets
Cash And Cash Equivalents 467,406
Net Receivables 110,028
Inventory 88,850
Other Current Assets 33
Total Current Assets  (as reported)680,499
Total Current Assets  (calculated)666,317
+/- 14,182
Long-term Assets
Property Plant Equipment 105,810
Long-term Assets Other 36,364
Long-term Assets  (as reported)142,174
Long-term Assets  (calculated)142,174
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities252,758
Long-term Liabilities20,443
Total Stockholder Equity549,472
Total Current Liabilities
Short Long Term Debt 89
Accounts payable 50,382
Other Current Liabilities 497
Total Current Liabilities  (as reported)252,758
Total Current Liabilities  (calculated)50,968
+/- 201,790
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt13,413
Long-term Liabilities Other 3,126
Long-term Liabilities  (as reported)20,443
Long-term Liabilities  (calculated)16,539
+/- 3,904
Total Stockholder Equity
Retained Earnings 62,261
Total Stockholder Equity (as reported)549,472
Total Stockholder Equity (calculated)62,261
+/- 487,211
Other
Capital Stock324,529
Common Stock Shares Outstanding 32,453
Net Invested Capital 549,561
Net Working Capital 427,741
Property Plant and Equipment Gross 105,810



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
732,309
680,389
750,183
772,987
787,620
812,530
822,673
822,673812,530787,620772,987750,183680,389732,309
   > Total Current Assets 
546,093
500,630
568,791
608,500
634,238
665,815
680,499
680,499665,815634,238608,500568,791500,630546,093
       Cash And Cash Equivalents 
320,764
272,777
344,419
380,317
472,955
463,496
467,406
467,406463,496472,955380,317344,419272,777320,764
       Net Receivables 
134,293
149,220
141,582
150,140
93,788
116,767
110,028
110,028116,76793,788150,140141,582149,220134,293
       Inventory 
87,917
70,652
76,649
63,559
56,167
73,696
88,850
88,85073,69656,16763,55976,64970,65287,917
       Other Current Assets 
1,594
2,759
737
288
16
12
33
3312162887372,7591,594
   > Long-term Assets 
186,216
179,759
181,392
164,487
153,382
146,715
142,174
142,174146,715153,382164,487181,392179,759186,216
       Property Plant Equipment 
147,273
135,325
146,735
131,749
122,410
113,011
105,810
105,810113,011122,410131,749146,735135,325147,273
       Other Assets 
35,792
44,309
34,558
32,664
30,924
33,681
0
033,68130,92432,66434,55844,30935,792
> Total Liabilities 
210,030
181,605
236,428
243,555
242,777
270,129
273,201
273,201270,129242,777243,555236,428181,605210,030
   > Total Current Liabilities 
204,821
175,785
215,728
224,552
225,174
254,591
252,758
252,758254,591225,174224,552215,728175,785204,821
       Short Long Term Debt 
1,328
794
36
43
184
159
89
8915918443367941,328
       Accounts payable 
77,636
62,237
88,677
73,655
48,007
65,337
50,382
50,38265,33748,00773,65588,67762,23777,636
       Other Current Liabilities 
127,185
113,548
124,870
148,242
153,182
429
497
497429153,182148,242124,870113,548127,185
   > Long-term Liabilities 
5,209
5,820
20,700
19,003
17,603
15,538
20,443
20,44315,53817,60319,00320,7005,8205,209
       Other Liabilities 
5,209
5,820
5,702
5,826
6,645
5,738
0
05,7386,6455,8265,7025,8205,209
       Deferred Long Term Liability 
0
0
0
3,500
2,793
0
0
002,7933,500000
> Total Stockholder Equity
522,279
498,784
513,755
529,432
544,843
542,401
549,472
549,472542,401544,843529,432513,755498,784522,279
   Common Stock
324,529
324,529
324,529
324,529
324,529
324,529
0
0324,529324,529324,529324,529324,529324,529
   Retained Earnings 
141,805
118,310
133,281
148,914
164,269
161,827
62,261
62,261161,827164,269148,914133,281118,310141,805
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 0000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue660,611
Cost of Revenue-441,066
Gross Profit219,545219,545
 
Operating Income (+$)
Gross Profit219,545
Operating Expense-592,817
Operating Income67,794-373,272
 
Operating Expense (+$)
Research Development13,770
Selling General Administrative137,981
Selling And Marketing Expenses0
Operating Expense592,817151,751
 
Net Interest Income (+$)
Interest Income5,180
Interest Expense-332
Other Finance Cost-0
Net Interest Income4,848
 
Pretax Income (+$)
Operating Income67,794
Net Interest Income4,848
Other Non-Operating Income Expenses0
Income Before Tax (EBT)78,65067,794
EBIT - interestExpense = -332
62,905
63,237
Interest Expense332
Earnings Before Interest and Taxes (EBIT)078,982
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax78,650
Tax Provision-15,745
Net Income From Continuing Ops62,90562,905
Net Income62,905
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-4,848
 

Technical Analysis of Level
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Level. The general trend of Level is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Level's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Level Biotechnology.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 32.90 > 32.20 > 31.75.

Tweet this
Level Biotechnology Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Level Biotechnology. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Level Biotechnology Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Level Biotechnology.

Level Biotechnology Daily Moving Average Convergence/Divergence (MACD) ChartLevel Biotechnology Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Level Biotechnology. The current adx is .

Level Biotechnology Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Level Biotechnology.

Level Biotechnology Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Level Biotechnology.

Level Biotechnology Daily Relative Strength Index (RSI) ChartLevel Biotechnology Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Level Biotechnology.

Level Biotechnology Daily Stochastic Oscillator ChartLevel Biotechnology Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Level Biotechnology.

Level Biotechnology Daily Commodity Channel Index (CCI) ChartLevel Biotechnology Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Level Biotechnology.

Level Biotechnology Daily Chande Momentum Oscillator (CMO) ChartLevel Biotechnology Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Level Biotechnology.

Level Biotechnology Daily Williams %R ChartLevel Biotechnology Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Level Biotechnology.

Level Biotechnology Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Level Biotechnology.

Level Biotechnology Daily Average True Range (ATR) ChartLevel Biotechnology Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Level Biotechnology.

Level Biotechnology Daily On-Balance Volume (OBV) ChartLevel Biotechnology Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Level Biotechnology.

Level Biotechnology Daily Money Flow Index (MFI) ChartLevel Biotechnology Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Level Biotechnology.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside

6.3. Candlestick Patterns

Level Biotechnology Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Level Biotechnology based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose32.750
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Level with someone you think should read this too:
  • Are you bullish or bearish on Level? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Level? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Level Biotechnology

I send you an email if I find something interesting about Level Biotechnology.


Comments

How you think about this?

Leave a comment

Stay informed about Level Biotechnology.

Receive notifications about Level Biotechnology in your mailbox!